XO
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP)
NASDAQ·Healthcare·Biotechnology
$24.98
—
Mkt Cap $311.64M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$250.70
Range $170.04 – $294.30
Implied Upside
+903.6%
Consensus $250.70 vs current $24.98